[Hemosorption in the complex treatment of rheumatic diseases].
The authors describe the results of the use of hemosorption in combined treatment of 42 patients with rheumatic diseases. The main group comprised patients with thromboangitis obliterans (23), nonspecific aortoarteritis was recognized in 6 cases, systemic scleroderma and systemic lupus erythematosus in 4, nodular periarteritis in 2. The functional skin tests were made with the aid of the KDU-3 unit, the level of the peripheral blood flow was measured with tetrapolar rheography and impedometry. The degree of redox processes and oxygen tension in the tissues was studied by the polarographic technique, the character of microcirculatory processes with the aid of biomicroscopy of the eyeball conjunctiva, the intensity of immunologic shifts by means of precipitation with polyethylene glycol at different dilutions. In addition, alterations in cellular and serum enzymes were also examined. The data obtained suggest that hemosorption is one of the effective additional methods of the treatment of patients with rheumatic diseases.
M P
MP
Vilianskiĭ
V I
VI
Alekseev
A G
AG
Pukhov
M A
MA
Lileeva
S Iu
SIu
Verkhovskii
D000328:Adult; D001025:Aortitis / Q000628:therapy*; D003131:Combined Modality Therapy; D003240:Connective Tissue Diseases / Q000628:therapy*; D003911:Dextrans / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006464:Hemoperfusion; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010488:Polyarteritis Nodosa / Q000628:therapy; D011239:Prednisolone / Q000008:administration & dosage; D012595:Scleroderma, Systemic / Q000628:therapy; D013919:Thromboangiitis Obliterans / Q000628:therapy*
D003911:Dextrans; D006493:Heparin; D011239:Prednisolone
Gemosorbtsiia v kompleksnoĭ terapii revmaticheskikh zabolevaniĭ.